TCL Archive FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion. February 8, 2008
TCL Archive On “Day One Of Post-Genome World,” Eric Lander Recounts 15-Year Journey. February 16, 2001
TCL Archive Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored December 10, 1982
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive DCE Board Approves Concept For New $850,000 Year Grant Program To Study Viruses In Cervical Cancer November 9, 1984
